Tiafenacil Patent Landscape Analysis

Discovered and developed by FarmHannong and commercialised through the Terrad'or brand, tiafenacil is a PPO-inhibiting uracil herbicide. It is used as a non-selective post-emergence burndown treatment against broadleaf and grass weeds, including glyphosate-resistant populations.

The report retains 16 patent families across 9 consolidated owner groups. Combination development is the largest and most competitive layer, comprising 9 families and naming 120 partner actives. The upstream estate includes 1 family in uracil compound claim, with 1 single-active formulation family.

A total of 11 families have a grant or national pending reading, while 1 live family reaches its nominal term within five years. One family is held by China-based applicants across 1 China-based owner group.

This 33-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, followed by a complete directory of all 9 owner groups. Detailed claim charts, remaining-space notes and owner profiles are included throughout.

Not a freedom-to-operate opinion.